Sarah Sinclair is the Medical Director of Hematology & Medical Oncology at Northern Light (NL) Cancer Care and the Director of Clinical Research. She joined NL Cancer Care in 2010 where she serves as Principal Investigator of multiple clinical trials including MCGI and TAPUR. Her interests include general oncology, breast cancer, clinical research, and precision medicine. After graduating from medical school at University of New England College of Osteopathic Medicine, she completed residency at University of Connecticut School of Medicine in internal medicine, and fellowship training at NIH/National Cancer Institute in hematology/oncology.